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ABSTRACT
Objective: To investigate the hypoglycemic and antihyperlipidemic effect of a successive ethanolic extract of Adiantum caudatum (EEAC) whole plant 
in alloxan induced diabetic rats.
Methods: Diabetes was induced in Wistar albino rats by the administration of alloxan (140 mg/kg b. w., i.p.). EEAC (200 mg/kg b. w., p.o.) was 
administered to diabetic rats for 21 days in alloxan induced diabetic rats. The effect of EEAC on blood glucose and body weight was studied in alloxan 
induced diabetic rats. All these effects were compared with glibenclamide (10 mg/kg b. w., p.o.) as a reference antidiabetic drug.
Results: The administration of EEAC (200 mg/kg b. w., p.o.) resulted in a significant decrease in blood glucose level and a significant increase in body 
weight in alloxan induced diabetic rats. Furthermore, EEAC showed antihyperlipidemic activity as evidenced by a significant decrease in serum total 
cholesterol and triglyceride levels in alloxan induced diabetic rats.
Conclusion: The results suggest that the EEAC possess a promising hypoglycemic effect in alloxan induced diabetic rats.
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INTRODUCTION
Diabetes mellitus (DM) is a chronic disease caused by inherited 
and/or acquired deficiency in the production of insulin by the 
pancreas or by the ineffectiveness of the insulin produced. Such 
a deficiency results in increased concentration of glucose in the 
blood (hyperglycemia), which in turn leads to metabolic disorders 
and also damage many of the body’s systems, in particular, the 
blood vessels and nerves [1]. It is also estimated that there are 
30‑33 million diabetic patients in India now and every fourth 
diabetic in the world today is an Indian. Indians are genetically more 
susceptible to diabetes, and the WHO predicts the number of diabetic 
persons in India would go up to 74 million by 2025 [2]. Apart from 
currently available therapeutic options, many herbal medicines 
have been recommended for treatment of diabetes. Furthermore 
after the recommendation made by WHO on DM, investigation 
on a hypoglycemic agent from medicinal plants has become more 
important [3]. The alloxan induced diabetic rat models have been 
regarded as one of the generally used animal model to detect the 
efficacy of test articles on diabetes.
The plant Adiantum caudatum is distinctive in appearance with dark, 
often black stripes and rachises, and bright green often delicately 
cut leaf tissue. The sori are borne submarginally and are covered by 
reflexed flaps of leaf tissue which resemble indusial. It generally prefers 
humus rich, moist, well‑drained sites ranging from bottomland soils to 
vertical rock walls. Three triterpenoids, 8a‑hydroxyfernan‑25, 7b‑olide, 
3a‑hydroxy‑4a‑methoxyfilicane, and 19a‑hydroxyferna‑7, 9 (11)‑diene 
were isolated from the fresh fronds of A. caudatum [4]. Coumarin is 
showed to be present in A. caudatum [5].
The present study is aimed at investigating the antidiabetic effect of 
a successive ethanolic extract of A. caudatum (whole plant) on blood 
glucose levels and other biochemical parameters in normoglycemic 
and alloxan induced diabetic rats. The present study is carried out to 
validate scientifically the folklore use of A. caudatum as antidiabetic.
METHODS
Collection of plant material
Fresh plant of A. caudatum was collected in the month of June 
from local areas of Chhaygaon, Guwahati, Assam and authenticated 
by Botanical Survey of India, Shillong, Meghalaya (Ref. no. Plant 
identification/14/297). Voucher specimen was deposited in 
departmental herbarium for future reference.
Preparation of extract
The collected plant materials were shade dried and subjected to size 
reduction to a coarse powder using a grinder and passed through 
a sieve. The powdered materials were extracted successively with 
petroleum ether, chloroform, and ethanol (40:60), respectively, at a 
temperature of 30‑50°C. All the extracts were further concentrated to 
semisolid mass using rota flash evaporator and were stored in desicator. 
The suspensions of ethanolic extracts were prepared by carboxymethyl 
cellulose (CMC) in distilled water for the experiment.
Phytochemical screening
The extract was tested to know the different constituents present 
in it by the standard procedures [6]. Terpenoids, phenyl propanoids, 
steroids, and flavonoids have been found in the plant A. caudatum.
Animals
Antidiabetic activity was carried out using healthy albino Wister 
rats of either sex weighing between 150 and 300 g. Animals 
were housed in polypropylene cages and allowed free access to 
tap water and pellet diet ad libitum throughout the study. After 
randomization into various groups and before initiation of the 
experiment, the rats were acclimatized for a period of 7‑day 
under standard environmental conditions of temperature, relative 
humidity, and dark/light cycle. All the experiments on animals were 
conducted according to ethical protocols that were approved by the 
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Acute toxicity study
Albino mice of either sex weighing between 20 and 30 g were used. The 
animals were fasted overnight. Acute toxicity was performed according 
to OECD guidelines; method followed is according to number 420 [7]. 
Effective dose for A. caudatum extract was found to be 200 mg/kg body 
weight.
Standard drug
Glibenclamide tablet (Daonil tablet, Aventis Pharma Pvt. Ltd.) was 
used as standard. It was purchased from New Multicare Pharmacy, 
Chhaygaon. The tablets were suspended in distilled water using CMC as 
suspending agent and used for the study.
Alloxan induced diabetes
The albino rats weighing 150‑300 g of either sex were allowed to fast 
for 12 hrs prior to experimentation and rendered diabetic by a single 
dose of i.p. injection of alloxan 140 mg/kg body weight as described 
by Joy and Kutton (1999) [8]. The antihyperglycemic activity on these 
animals was carried out after 5 days of alloxan injection when the 
stabilization of diabetes was ensured. The animals with sugar level 
more than 200 mg/dl were selected for the study [9‑13].
Experimental design
All the animals were randomly divided into five groups.
Group 1:  Healthy normal animals received only the vehicle (CMC).
Group 2:   Untreated but diabetes‑induced animals served as a negative 
control.
Group 3:   Diabetes‑induced animals and treated with standard drug 
glibenclamide 10 mg/kg body weight/day orally.
Group 4:  Diabetic animals and treated with a successive ethanolic 
extract of A. caudatum (EEAC).
The extract was given orally at the dose of 200 mg/kg body weight, 
respectively, and the study was carried out for a period of 21‑day.
On the 21st day of treatment, blood samples were collected by 
retro‑orbital plexus puncture method under mild ether anesthesia, and 
serum was separated by centrifugation. The serum was analyzed for 
blood glucose level, total cholesterol, and total triglyceride level.
Statistical analysis
The quantitative measurements were made on six animals in each 
group, and the values of biochemical estimations were expressed as 
mean ± standard error of the mean. The data obtained were subjected 
to one‑way ANOVA by multiple comparison tests.
RESULTS
Effect of EEAC on blood glucose levels in alloxan induced diabetic 
rats
The effect of EEAC on blood glucose levels of diabetic rats is given in 
Table 1. Alloxan induced diabetic rats showed a significant increase 
in blood glucose levels when compared to normal control rats. Oral 
administration of EEAC at 200 mg/kg b.w. showed a significant 
decrease (p < 0.001) in blood glucose levels.
Effect of EEAC on body weight in alloxan induced diabetic rats
Body weight of animals in all groups was recorded before and after 
treatment and change in body weight was also mentioned. The highest 
change in body weight during the study period was found to be in the 
diabetic control group which decreases. In all treatment group with 
200 mg/kg of EEAC body weight was increased, P < 0.001 (Table 2).
Effect of EEAC on biochemical parameters in alloxan induced 
diabetic rats
EEAC at a dose of 200 mg/kg b. w. significantly decreases total 
cholesterol and total triglyceride levels (p < 0.001). Glibenclamide 
10 mg/kg b.w. significantly decreases total cholesterol and triglyceride 
levels (p < 0.001) (Table 3).
Histopathology of pancreas in alloxan induced diabetic rats
From the histopathological examinations (Fig. 1) of the pancreas, in the 
normal control group, the islet boundaries were clear, and the profiles 
of the islet cells were clearly visible. No necrosis or fatty degeneration 
observed. After inducing alloxan, in diabetic control group completely 
destructed cells were observed, ballooning, picnosis, and Necrosis 
occurred. There was fatty layer degeneration, normal eco‑structure 
had been lost, central lobes were destroyed; normal cellular integrity 
was completely lost along with fatty degeneration. Irregular gap 
junctions appeared coagulation occurred due to necrosis. In test 
control group (200 mg/kg of bodyweight), central Lobule is intact, 
cellular integrity was normal to a great extent. In standard treated 
Group (10 mg/kg of b.w.), cellular integrity was normal. Fatty layer 
degeneration had occurred. Slight ballooning occurred, but no blood 
clotting or necrosis had been noticed.
DISCUSSION
The successive ethanolic extract A. caudatum was effective in 
normalizing the elevated levels of blood sugar and blood lipid‑like 
cholesterol, triglycerides. Results are comparable with that of reference 
Table 2: Effect of EEAC on body weight in alloxan induced 
diabetic rats
Groups Before treatment After treatment
Normal control 230±0.6831 232±0.3651
Diabetic control 220±0.4472 207.3±4.014a***
Standard drug 220±0.4472 232±0.5774b***
EEAC 210±0.5164 218±0.2582b***
Each value is mean±SEM of 6 rats in each group. ***p<0.001 in comparison 
to diabetic control, SEM: Standard error of mean, EEAC: Successive ethanolic 
extract of Adiantum caudatum. Where, aNormal control, bDiabetic control
Table 3: Effect of EEAC on biochemical parameters in alloxan 
induced diabetic rats
Groups Biochemical parameters (mg/dl)
Total cholesterol Total triglyceride
Normal control 33.72±0.2957 72.45±0.1965
Diabetic control 86.01±0.1828a*** 175.2±0.2853a***
Standard drug 62.04±0.1003b*** 84.43±0.2482b***
EEAC 63.52±0.1830b*** 87.37±0.2088b***
Each value is mean±SEM of 6 rats in each group. ***p<0.001 in comparison 
to diabetic control, SEM: Standard error of mean, EEAC: Successive ethanolic 
extract of Adiantum caudatum. Where, aNormal control, bDiabetic control
Table 1: Effect of EEAC on blood glucose level in alloxan induced diabetic rats
Groups 0 day 7th day 14th day 21st day
Normal control 82.58±0.2789 83.28±0.08139 81.53±0.1078 82.77±0.1573
Diabetic control 316.7±0.1392 354.7±0.15a*** 378.7±0.194a*** 342.7±0.3032a***
Standard drug 315.4±0.2659 242.3±0.4751b*** 138.1±0.3754b*** 148.8±0.3025b***
EEAC 314.5±0.28 234.6±0.288b*** 162.2±0.3769b*** 174.3±0.7786b**
Each value is mean±SEM of 6 rats in each group. **p<0.01, ***p<0.001 in comparison to diabetic control, SEM: Standard error of mean, EEAC: Successive ethanolic 
extract of Adiantum caudatum, Where, aNormal control, bDiabetic control
363
Asian J Pharm Clin Res, Vol 9, Issue 1, 2016, 361-363
 Saha et al. 
drug glibenclamide. The phytochemical screening of the extract 
revealed the presence of flavonoids, alkaloids, phenolic compounds, 
carbohydrates, and triterpenoids.
Administration of alloxan (140 mg/kg, i.p.) let to an elevation of fasting 
blood glucose levels, which was maintained throughout the period of 
treatment for 21‑day of daily treatment of EEAC led to a fall in blood 
sugar levels. The effect seems to reach a maximum after 14 days of 
treatment. Vehicle‑controlled animals were found to be somewhat 
stable in their body weight, but diabetic rats showed a significant 
reduction in body weight during the entire experiment.
In light of the results, our study indicates that successive ethanolic 
extract of A. caudatum without significant change in body weight 
(200 mg/kg b.w.) exhibited significant antidiabetic activity in alloxan 
induced hyperglycemic rat. The antidiabetic effect may be due to 
the presence of flavonoids, phenolic compounds, alkaloids, and 
triterpenoids. Thus, the claim made by the traditional Indian system of 
medicine regarding the use of this plant in the treatment of diabetes 
stands confirmed.
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Fig. 1: Histopathology of pancreas in alloxan induced diabetic 
rats. (a) Normal control, (b) Diabetic control, (c) Standard 
drug, (d) Successive ethanolic extract of Adiantum caudatum 
(200 mg/kg b.w.)
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